Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,187 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07648914RecruitingPhase 3
BL-B01D1 versus chemotherapy for advanced hormone-receptor-positive breast cancer
This trial tests a new targeted drug called BL-B01D1 against standard chemotherapy in patients with advanced breast cancer that is hormone-receptor-positive (HR+) and HER2-negative, and has stopped responding to hormone treatments. The goal is to see if the new drug works better or has fewer side effects.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07652281RecruitingPhase 1
Study of SHR-5421 for multiple myeloma
This trial tests a new drug, SHR-5421, for people with multiple myeloma that has come back or stopped responding to treatment. It aims to see if the drug is safe and how well it works.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07654400RecruitingPhase 2
Study of BL-M14D1 plus Atezolizumab for advanced small cell lung cancer
This trial tests a new drug combination (BL-M14D1 and Atezolizumab) for people with extensive-stage small cell lung cancer that has not responded to standard treatments. The goal is to see if the combination can shrink tumors or slow the growth of the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07651878RecruitingPhase 1
Vididencel immunotherapy for chronic myeloid leukemia with minimal residual disease
This study tests whether an experimental immune therapy called vididencel can help patients with chronic myeloid leukemia (CML) who have responded partially to standard tyrosine kinase inhibitor (TKI) drugs. The goal is to see if this therapy can further reduce the cancer cells remaining in their body.
BergenAges 18 years+ - NCT07650227RecruitingPhase 3
Raphamin for treating acute bronchitis in adults
This study tests whether a medicine called Raphamin can safely and effectively treat acute bronchitis (a chest infection with cough) in adults. Raphamin may help reduce cough and breathing problems in the early stages of this condition.
AramilAges 18–64 - NCT07653685RecruitingPhase 1/Phase 2
Study of a new drug with chemotherapy for advanced colorectal cancer
This trial tests a new drug (TQB2930) combined with chemotherapy, with or without another drug called bevacizumab, for people whose colorectal cancer has spread or cannot be removed by surgery and has a specific protein called HER2. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT07654855Recruiting
Long-term safety of eplontersen in ATTR patients
This study follows people who already took part in an earlier trial (D8450R00003) to see how safe eplontersen is over the long term. It also includes people who had a liver transplant or severe liver problems.
Los Angeles, CaliforniaAges 18 years+ - NCT07647172Recruiting
Flavonoid Treatment for Hemorrhoids After Minimally Invasive Surgery
This study tests whether a plant-based medicine called MPFF (a purified flavonoid fraction) helps reduce symptoms and improve healing after minimally invasive surgery for hemorrhoids. You would take this medicine before and after your scheduled procedure.
MoscowAges 18 years+ - NCT07646613RecruitingPhase 2
Testing an inhaled migraine medicine for quick relief
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Phoenix, ArizonaAges 18–65 - NCT06055569Recruiting
Rehabilitation for arm recovery after stroke using observation and muscle stimulation
This trial tests if observing arm movements paired with muscle stimulation helps stroke survivors regain arm function. It may be an option if your stroke affected one arm and you are between two weeks and six months post-stroke.
Milan, ItaliaAges 18 years+ - NCT06682156Recruiting
Switching to carfilzomib for multiple myeloma patients who can't tolerate bortezomib
This trial is for people newly diagnosed with multiple myeloma who are having side effects from their first treatment with bortezomib. It tests switching to a different drug called carfilzomib to see if it works well with fewer side effects.
Suzhou, JiangsuAges 18 years+ - NCT06685562Recruiting
Testing a map to help make cancer decisions together
This study tests a new way to help people with cancer and their doctors make decisions together. If you have prostate, breast, or melanoma cancer, this trial may help you understand your options better.
VejleAges 18 years+ - NCT05396170Recruiting
Blood draws to lower heart rate in blood-thickening disease
This trial studies whether regular blood removal (phlebotomy) can change your heart rate in people with polycythaemia who already need these blood draws regularly. If you qualify, you may be asked to use a smartphone during the study so researchers can track your heart rate changes over time.
Leiden, South HollandAges 18 years+ - NCT06345118Recruiting
Fall prevention for older adults with type 2 diabetes
This trial studies a fall prevention program for older adults with type 2 diabetes. The goal is to see if it reduces falls and improves safety.
HanoiAges 60–60 - NCT07649928RecruitingEarly Phase 1
Testing ES502 for Advanced Pancreatic and Other Cancers
This early-stage trial tests a new drug called ES502 for patients with advanced cancers (including pancreatic cancer) that have a specific genetic mutation and certain immune markers. The study aims to find the right dose and see if it helps shrink tumors.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07651436Recruiting
Depression screening in patients on kidney dialysis
This study tests whether nurses can effectively screen for depression in patients receiving regular kidney dialysis treatment. The goal is to find the best way to identify depression early so patients can get help.
AnnecyAges 18 years+ - NCT07646418Recruiting
Light therapy and blood-flow restriction for stroke recovery
This study tests whether combining light therapy with blood-flow restriction exercise (a technique that limits blood flow during gentle movement) helps improve arm strength and reduce muscle stiffness in people recovering from stroke. The goal is to see if this combination works better than standard treatment.
Sialkot, Punjab ProvinceAges 50–70 - NCT07653022Enrolling by invitation
Turkish symptom questionnaire for Turkish speakers with language barriers
This study tests a Turkish version of a questionnaire for Turkish-speaking patients who have psychological complaints but face language barriers. It aims to help doctors better understand their symptoms.
Jette, Brussels CapitalAges 18 years+ - NCT07646977Recruiting
Blood Clot Treatment for Heart Attack Recovery
This trial tests a new approach to treating blood clots during a heart attack to prevent damage to the small blood vessels in your heart. You would receive this treatment during an emergency catheterization procedure if you have signs of a major heart attack.
OdenseAges 18 years+ - NCT07647250Recruiting
Physical activity study for pancreatic cancer patients before surgery
This study tests if a personalized physical activity program can help pancreatic cancer patients who are receiving chemotherapy before surgery. It is designed for patients who feel weak or have early signs of frailty.
Chicago, IllinoisAges 18 years+ - NCT07653321Enrolling by invitation
Kidney injury in critically ill patients
This study looks at acute kidney injury in patients who are very sick in the intensive care unit (ICU). It may help doctors better understand and manage kidney problems in these patients.
BeijingAges 18 years+ - NCT07647471Recruiting
Exercise program for children starting cancer treatment
This study tests whether gentle exercise during cancer treatment helps children feel better and recover faster. Researchers will guide kids through age-appropriate activities while they receive their cancer therapy.
BerlinAges 3–18 - NCT07651891RecruitingPhase 4
Dog allergy vaccine study for Swedish adults
This study tests an allergy shot (Alutard SQ Dog) for people with moderate to severe dog allergies. It aims to see how well the vaccine works in Swedish medical practices.
Lund, Skåne CountyAges 18–50 - NCT07650474Recruiting
Mobile app for heart failure management and quality of life
This study tests whether using a mobile phone app to monitor and manage chronic heart failure improves how you feel and function day-to-day. Researchers will check in with you regularly through your phone to track your symptoms and health.
Addis AbabaAges 18–65
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,187 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.